Drug intelligence / Profile preview

Sancai Powder

Development stage: Unknown
Lead developer: Hospital of Chengdu University of Traditional Chinese Medicine
Administration: Oral

Overview

Sancai Powder is a Traditional Chinese Medicine (TCM) herbal formulation developed and studied by The Hospital of Chengdu University of Traditional Chinese Medicine. It is primarily indicated for the treatment of type 2 diabetes mellitus, with a specific focus on reducing glycemic variability in elderly patients. The formulation is based on the "Sancai" (Three Talents) principle, traditionally comprising three core herbs: *Ren Shen* (Ginseng), *Tian Men Dong* (Asparagus cochinchinensis), and *Sheng Di Huang* (Rehmannia glutinosa). These ingredients are thought to work synergistically to nourish Yin, tonify Qi, and clear heat, thereby stabilizing blood glucose levels and potentially mitigating diabetic complications.

Other names: Sancai San三才粉

Beyond the preview

Go deeper on Sancai Powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sancai Powder.

Explore the full profile